Molecular insights into MYO3A kinase domain variants explain variability in both severity and progression of DFNB30 hearing impairment.
J Biomol Struct Dyn
; 40(21): 10940-10951, 2022.
Article
in En
| MEDLINE
| ID: mdl-34423747
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Myosin Type III
/
Hearing Loss
/
Hearing Loss, Sensorineural
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
J Biomol Struct Dyn
Year:
2022
Type:
Article
Affiliation country:
Tunisia